CN111280257A - Immunoglobulin formula goat milk powder - Google Patents
Immunoglobulin formula goat milk powder Download PDFInfo
- Publication number
- CN111280257A CN111280257A CN202010342789.4A CN202010342789A CN111280257A CN 111280257 A CN111280257 A CN 111280257A CN 202010342789 A CN202010342789 A CN 202010342789A CN 111280257 A CN111280257 A CN 111280257A
- Authority
- CN
- China
- Prior art keywords
- vitamin
- parts
- milk powder
- goat milk
- immunoglobulin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000843 powder Substances 0.000 title claims abstract description 27
- 235000020251 goat milk Nutrition 0.000 title claims abstract description 21
- 108060003951 Immunoglobulin Proteins 0.000 title claims abstract description 16
- 102000018358 immunoglobulin Human genes 0.000 title claims abstract description 16
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 34
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims abstract description 17
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims abstract description 16
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 claims abstract description 16
- QGNJRVVDBSJHIZ-QHLGVNSISA-N retinyl acetate Chemical compound CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C QGNJRVVDBSJHIZ-QHLGVNSISA-N 0.000 claims abstract description 15
- 239000011626 DL-alpha-tocopherylacetate Substances 0.000 claims abstract description 8
- 235000001809 DL-alpha-tocopherylacetate Nutrition 0.000 claims abstract description 8
- 239000002211 L-ascorbic acid Substances 0.000 claims abstract description 8
- 235000000069 L-ascorbic acid Nutrition 0.000 claims abstract description 8
- 229960005070 ascorbic acid Drugs 0.000 claims abstract description 8
- 229910000019 calcium carbonate Inorganic materials 0.000 claims abstract description 8
- 239000011790 ferrous sulphate Substances 0.000 claims abstract description 8
- 235000003891 ferrous sulphate Nutrition 0.000 claims abstract description 8
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 claims abstract description 8
- 229910000359 iron(II) sulfate Inorganic materials 0.000 claims abstract description 8
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 claims abstract description 8
- 239000011764 pyridoxine hydrochloride Substances 0.000 claims abstract description 8
- 229960004172 pyridoxine hydrochloride Drugs 0.000 claims abstract description 8
- 235000005282 vitamin D3 Nutrition 0.000 claims abstract description 8
- 239000011647 vitamin D3 Substances 0.000 claims abstract description 8
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 claims abstract description 8
- 229940021056 vitamin d3 Drugs 0.000 claims abstract description 8
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 claims abstract description 8
- 229960001763 zinc sulfate Drugs 0.000 claims abstract description 8
- 229910000368 zinc sulfate Inorganic materials 0.000 claims abstract description 8
- 229960000342 retinol acetate Drugs 0.000 claims abstract description 7
- 235000019173 retinyl acetate Nutrition 0.000 claims abstract description 7
- 239000011770 retinyl acetate Substances 0.000 claims abstract description 7
- ZAKOWWREFLAJOT-UHFFFAOYSA-N DL-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 claims abstract description 5
- 229940117373 dl-alpha tocopheryl acetate Drugs 0.000 claims abstract description 5
- 239000002994 raw material Substances 0.000 claims description 8
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 claims description 3
- 229940042585 tocopherol acetate Drugs 0.000 claims description 3
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 abstract description 26
- 229910052742 iron Inorganic materials 0.000 abstract description 13
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 abstract description 10
- 238000010521 absorption reaction Methods 0.000 abstract description 10
- 239000011575 calcium Substances 0.000 abstract description 10
- 229910052791 calcium Inorganic materials 0.000 abstract description 10
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 abstract description 9
- 229930003268 Vitamin C Natural products 0.000 abstract description 9
- 229930003316 Vitamin D Natural products 0.000 abstract description 9
- 239000011726 vitamin B6 Substances 0.000 abstract description 9
- 235000019154 vitamin C Nutrition 0.000 abstract description 9
- 239000011718 vitamin C Substances 0.000 abstract description 9
- 235000019166 vitamin D Nutrition 0.000 abstract description 9
- 239000011710 vitamin D Substances 0.000 abstract description 9
- 150000003710 vitamin D derivatives Chemical class 0.000 abstract description 9
- 229940046008 vitamin d Drugs 0.000 abstract description 9
- 235000015097 nutrients Nutrition 0.000 abstract description 8
- 241000282414 Homo sapiens Species 0.000 abstract description 7
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 abstract description 6
- LXNHXLLTXMVWPM-UHFFFAOYSA-N Vitamin B6 Natural products CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 abstract description 6
- 102000004169 proteins and genes Human genes 0.000 abstract description 6
- 108090000623 proteins and genes Proteins 0.000 abstract description 6
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 abstract description 6
- 235000019158 vitamin B6 Nutrition 0.000 abstract description 6
- 229940011671 vitamin b6 Drugs 0.000 abstract description 6
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 abstract description 4
- 229910052500 inorganic mineral Inorganic materials 0.000 abstract description 4
- 239000011707 mineral Substances 0.000 abstract description 4
- 235000010755 mineral Nutrition 0.000 abstract description 4
- 239000011701 zinc Substances 0.000 abstract description 4
- 229910052725 zinc Inorganic materials 0.000 abstract description 4
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 abstract description 3
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 abstract description 3
- 229930003427 Vitamin E Natural products 0.000 abstract description 3
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 abstract description 3
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 abstract description 3
- 230000004060 metabolic process Effects 0.000 abstract description 3
- 230000001737 promoting effect Effects 0.000 abstract description 3
- 230000001502 supplementing effect Effects 0.000 abstract description 3
- 235000019155 vitamin A Nutrition 0.000 abstract description 3
- 239000011719 vitamin A Substances 0.000 abstract description 3
- 229940046009 vitamin E Drugs 0.000 abstract description 3
- 235000019165 vitamin E Nutrition 0.000 abstract description 3
- 239000011709 vitamin E Substances 0.000 abstract description 3
- 229940045997 vitamin a Drugs 0.000 abstract description 3
- 235000013305 food Nutrition 0.000 abstract description 2
- 229940088594 vitamin Drugs 0.000 abstract description 2
- 229930003231 vitamin Natural products 0.000 abstract description 2
- 235000013343 vitamin Nutrition 0.000 abstract description 2
- 239000011782 vitamin Substances 0.000 abstract description 2
- 229960003563 calcium carbonate Drugs 0.000 abstract 1
- 229960001781 ferrous sulfate Drugs 0.000 abstract 1
- 235000013336 milk Nutrition 0.000 description 7
- 239000008267 milk Substances 0.000 description 7
- 210000004080 milk Anatomy 0.000 description 7
- 239000000047 product Substances 0.000 description 6
- 210000003022 colostrum Anatomy 0.000 description 5
- 235000021277 colostrum Nutrition 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 description 4
- 229940107187 fructooligosaccharide Drugs 0.000 description 4
- DLRVVLDZNNYCBX-RTPHMHGBSA-N isomaltose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-RTPHMHGBSA-N 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 235000018102 proteins Nutrition 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 230000035764 nutrition Effects 0.000 description 3
- 235000013406 prebiotics Nutrition 0.000 description 3
- 241000186000 Bifidobacterium Species 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 235000013325 dietary fiber Nutrition 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 235000020256 human milk Nutrition 0.000 description 2
- 210000004251 human milk Anatomy 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 230000007413 intestinal health Effects 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 241000186018 Bifidobacterium adolescentis Species 0.000 description 1
- 241001608472 Bifidobacterium longum Species 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 102000014171 Milk Proteins Human genes 0.000 description 1
- 108010011756 Milk Proteins Proteins 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 229940009291 bifidobacterium longum Drugs 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 235000020247 cow milk Nutrition 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 238000005238 degreasing Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 235000019007 dietary guidelines Nutrition 0.000 description 1
- 238000007580 dry-mixing Methods 0.000 description 1
- 230000009982 effect on human Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000021239 milk protein Nutrition 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
- A23C9/1522—Inorganic additives, e.g. minerals, trace elements; Chlorination or fluoridation of milk; Organic salts or complexes of metals other than natrium or kalium; Calcium enrichment of milk
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
- A23C9/158—Milk preparations; Milk powder or milk powder preparations containing additives containing vitamins or antibiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/16—Agglomerating or granulating milk powder; Making instant milk powder; Products obtained thereby
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Inorganic Chemistry (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention relates to the technical field of food, and in particular relates to an immunoglobulin formula goat milk powder which comprises retinyl acetate, cholecalciferol, dl-alpha-tocopheryl acetate, pyridoxine hydrochloride, L-ascorbic acid, ferrous sulfate, zinc sulfate and calcium carbonate. It is tested to include various vitamins such as vitamin A, vitamin D, vitamin E, vitamin C and vitamin B6. In addition, the iron-rich mineral is rich in elements such as iron, zinc, calcium and the like. The goat milk powder of the embodiment is helpful for supplementing various nutrients required by a human body, and the nutrients have the efficacy of mutually promoting absorption, such as: vitamin D + calcium, vitamin D can promote the absorption of calcium; protein + vitamin B6, vitamin B6 is helpful for the metabolism and utilization of protein; vitamin C + iron, vitamin C can promote the absorption of iron.
Description
Technical Field
The invention relates to the technical field of food, and in particular relates to an immunoglobulin formula goat milk powder.
Background
The dairy product provides dense nutrients for human beings, and the Chinese dietary guidelines recommend that 300mL of milk be consumed daily. Compared with cow milk, the goat milk has the advantages that the milk protein is closer to human milk, is not easy to be allergic and is easier to digest and absorb; the goat milk fat globules are small and easy to digest, and are helpful for reducing the cholesterol level; the content and the type of the goat milk oligosaccharide are relatively close to those of human milk.
The dietary fiber is a polymer of carbohydrate naturally existing in plants, extracted or synthesized, and has a polymerization degree DP of more than or equal to 3, cannot be digested and absorbed by small intestine of human body, and has health significance to human body. In recent years, along with the improvement of living standard of people, the attention of people to health is increased day by day, and water-soluble dietary fibers also enter the visual field of people, and generally have the effects of regulating the intestines, regulating blood fat, regulating blood sugar value, reducing cholesterol and resisting decayed teeth.
Disclosure of Invention
The application provides an immunoglobulin formula goat milk powder which is beneficial to absorption and high in nutrition conversion rate.
The immunoglobulin formula goat milk powder comprises the following raw materials in parts by weight:
0.6-0.7 part of retinyl acetate, 0.008-0.012 part of cholecalciferol, 20-24 parts of dl-alpha-tocopherol acetate, 1-1.4 parts of pyridoxine hydrochloride, 80-90 parts of L-ascorbic acid, 10-20 parts of ferrous sulfate, 4-6 parts of zinc sulfate and 350 parts of calcium carbonate.
In one embodiment, the material comprises the following raw materials in parts by weight:
0.65 part of retinyl acetate, 0.01 part of cholecalciferol, 22 parts of dl-alpha-tocopheryl acetate, 1.2 parts of pyridoxine hydrochloride, 85 parts of L-ascorbic acid, 14 parts of ferrous sulfate, 5.1 parts of zinc sulfate and 300 parts of calcium carbonate.
The immunoglobulin formula goat milk powder according to the above embodiment includes a plurality of vitamins such as vitamin A, vitamin D, vitamin E, vitamin C and vitamin B6. In addition, the iron-rich mineral is rich in elements such as iron, zinc, calcium and the like. The goat milk powder of the embodiment is helpful for supplementing various nutrients required by a human body, and the nutrients have the efficacy of mutually promoting absorption, such as: vitamin D + calcium, vitamin D can promote the absorption of calcium; protein + vitamin B6, vitamin B6 is helpful for the metabolism and utilization of protein; vitamin C + iron, vitamin C can promote the absorption of iron. Therefore, compared with the existing milk powder, the goat milk powder of the embodiment is easier to absorb and has high nutrition conversion rate.
Detailed Description
The present invention will be described in further detail with reference to the following embodiments. Wherein like elements in different embodiments are numbered with like associated elements. In the following description, numerous details are set forth in order to provide a better understanding of the present application. However, those skilled in the art will readily recognize that some of the features may be omitted or replaced with other elements, materials, methods in different instances. In some instances, certain operations related to the present application have not been shown or described in detail in order to avoid obscuring the core of the present application from excessive description, and it is not necessary for those skilled in the art to describe these operations in detail, so that they may be fully understood from the description in the specification and the general knowledge in the art.
The product selects isomaltooligosaccharide and fructo-oligosaccharide as formula materials, the isomaltooligosaccharide can be well utilized by various bifidobacteria, the proliferation rate is high, and the utilization degree of the isomaltooligosaccharide by bifidobacterium longum and bifidobacterium adolescentis is high; fructo-oligosaccharide is the main representative of prebiotics, the prebiotics function is outstanding, and research shows that the fructo-oligosaccharide has 100 times of proliferation effect on bifidobacteria in intestinal tracts. The compound of the two prebiotics has good efficacy in improving the intestinal health, and the improvement of the intestinal health is also beneficial to improving the immunity of human bodies.
The first embodiment is as follows:
the embodiment provides an immunoglobulin formula goat milk powder, which comprises the following raw materials in parts by weight: 0.6-0.7 part of retinyl acetate, 0.008-0.012 part of cholecalciferol, 20-24 parts of dl-alpha-tocopherol acetate, 1-1.4 parts of pyridoxine hydrochloride, 80-90 parts of L-ascorbic acid, 10-20 parts of ferrous sulfate, 4-6 parts of zinc sulfate and 350 parts of calcium carbonate.
Through detection, the milk powder of the embodiment is rich in vitamin A, vitamin D, vitamin E, vitamin C and vitamin B6In addition, the iron-rich mineral is rich in elements such as iron, zinc, calcium and the like. The goat milk powder of the embodiment is helpful for supplementing various nutrients required by a human body, and the nutrients have the efficacy of mutually promoting absorption, such as: vitamin D + calcium, vitamin D can promote the absorption of calcium; protein + vitamin B6, vitamin B6 is helpful for the metabolism and utilization of protein; vitamin C + iron, vitamin C can promote the absorption of iron. Therefore, compared with the existing milk powder, the goat milk powder of the embodiment is easier to absorb and has high nutrition conversion rate.
Example two
The embodiment provides an immunoglobulin formula goat milk powder, which comprises the following raw materials in parts by weight: 0.65 part of retinyl acetate, 0.01 part of cholecalciferol, 22 parts of dl-alpha-tocopheryl acetate, 1.2 parts of pyridoxine hydrochloride, 85 parts of L-ascorbic acid, 14 parts of ferrous sulfate, 5.1 parts of zinc sulfate and 300 parts of calcium carbonate.
EXAMPLE III
The present embodiment provides an immunoglobulin formula goat milk powder, which comprises the following raw materials and their proportions as shown in table 1:
TABLE 1
| Name of nutrient | GB14880/100g | Sources of Compounds | Reinforcement value/100 g |
| VA（μg RE） | 300-900 | Acetic acid retinyl ester | 0.65 |
| VD（μg） | 6.3-12.5 | Cholecalciferol | 0.01 |
| VE（mg a-TE） | 10-31 | dl-alpha-tocopheryl acetate | 22 |
| VB6（μg） | 800-1600 | Pyridoxine hydrochloride | 1.2 |
| VC（mg） | 30-100 | L-ascorbic acid | 85 |
| Iron (mg) | 6-20 | Ferrous sulfate | 14 |
| Zinc (mg) | 3-6 | Zinc sulfate | 5.1 |
| Calcium (mg) | 300-720 | Calcium carbonate | 300 |
The colostrum powder in the milk powder is a powdery or fine-crystalline product prepared from bovine colostrum and sheep colostrum serving as raw materials through processes of sterilization, centrifugal degreasing, low-temperature drying and the like, and immunoglobulin (IgG) with a good effect on human immunity is reserved through the low-temperature drying process.
The product takes raw goat milk, isomaltooligosaccharide, fructo-oligosaccharide, multivitamins and minerals as basic ingredients, forms base powder after standardized ingredients, sterilization, concentration and spray drying, and then forms a final product-modified milk powder by adding colostrum powder through a dry process, the final product has uniform particles and sweet and mellow taste, simultaneously keeps immunoglobulin (IgG) not to be damaged to the maximum extent, and the addition amount of the immunoglobulin (IgG) in the final product reaches: 200mg/100g, the whole formula design is superior to similar products in the market, so that the health food can play an obvious role in regulating immunity and improving sub-health state after being eaten by consumers.
The production process of the milk powder of the embodiment is divided into the following two stages:
in the first stage, a product containing a basic formula is produced by adopting a wet process;
in the second stage, the product containing the base formula produced by the wet process is added to a colostrum powder containing immunoglobulin (IgG) in a dry mixing process.
The present invention has been described in terms of specific examples, which are provided to aid understanding of the invention and are not intended to be limiting. For a person skilled in the art to which the invention pertains, several simple deductions, modifications or substitutions may be made according to the idea of the invention.
Claims (2)
1. The immunoglobulin formula goat milk powder is characterized by comprising the following raw materials in parts by weight:
0.6-0.7 part of retinyl acetate, 0.008-0.012 part of cholecalciferol, 20-24 parts of dl-alpha-tocopherol acetate, 1-1.4 parts of pyridoxine hydrochloride, 80-90 parts of L-ascorbic acid, 10-20 parts of ferrous sulfate, 4-6 parts of zinc sulfate and 350 parts of calcium carbonate.
2. The immunoglobulin formula goat milk powder of claim 1, comprising the following raw materials in parts by weight:
0.65 part of retinyl acetate, 0.01 part of cholecalciferol, 22 parts of dl-alpha-tocopheryl acetate, 1.2 parts of pyridoxine hydrochloride, 85 parts of L-ascorbic acid, 14 parts of ferrous sulfate, 5.1 parts of zinc sulfate and 300 parts of calcium carbonate.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010342789.4A CN111280257A (en) | 2020-04-27 | 2020-04-27 | Immunoglobulin formula goat milk powder |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010342789.4A CN111280257A (en) | 2020-04-27 | 2020-04-27 | Immunoglobulin formula goat milk powder |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN111280257A true CN111280257A (en) | 2020-06-16 |
Family
ID=71017387
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010342789.4A Pending CN111280257A (en) | 2020-04-27 | 2020-04-27 | Immunoglobulin formula goat milk powder |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN111280257A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112244095A (en) * | 2020-10-22 | 2021-01-22 | 成都诺臻生物科技有限公司 | Milk powder for regulating immunity and preparation method thereof |
| CN112544722A (en) * | 2020-11-03 | 2021-03-26 | 湖南科尔生物技术有限公司 | Solid beverage rich in sheep colostrum and preparation method and application thereof |
| CN112741158A (en) * | 2020-12-29 | 2021-05-04 | 赵新法 | Novel goat milk powder and preparation method thereof |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102283289A (en) * | 2011-09-15 | 2011-12-21 | 澳优乳业（中国）有限公司 | Anti-inflaming infant formula milk powder and preparation process thereof |
| CN102599260A (en) * | 2012-04-19 | 2012-07-25 | 湖南欧能达婴童用品营销有限公司 | Goat milk powder for infants |
| CN110063371A (en) * | 2018-01-23 | 2019-07-30 | 天津澳斯乳业有限公司 | A kind of infant formula goat milk powder and its production method |
| CN110063372A (en) * | 2018-01-23 | 2019-07-30 | 天津澳斯乳业有限公司 | A kind of infant formula goat milk powder and its production method |
| CN110604180A (en) * | 2018-06-14 | 2019-12-24 | 福建省康恒食品科技有限公司 | Formula and preparation process of novel infant milk powder |
-
2020
- 2020-04-27 CN CN202010342789.4A patent/CN111280257A/en active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102283289A (en) * | 2011-09-15 | 2011-12-21 | 澳优乳业（中国）有限公司 | Anti-inflaming infant formula milk powder and preparation process thereof |
| CN102599260A (en) * | 2012-04-19 | 2012-07-25 | 湖南欧能达婴童用品营销有限公司 | Goat milk powder for infants |
| CN110063371A (en) * | 2018-01-23 | 2019-07-30 | 天津澳斯乳业有限公司 | A kind of infant formula goat milk powder and its production method |
| CN110063372A (en) * | 2018-01-23 | 2019-07-30 | 天津澳斯乳业有限公司 | A kind of infant formula goat milk powder and its production method |
| CN110604180A (en) * | 2018-06-14 | 2019-12-24 | 福建省康恒食品科技有限公司 | Formula and preparation process of novel infant milk powder |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112244095A (en) * | 2020-10-22 | 2021-01-22 | 成都诺臻生物科技有限公司 | Milk powder for regulating immunity and preparation method thereof |
| CN112544722A (en) * | 2020-11-03 | 2021-03-26 | 湖南科尔生物技术有限公司 | Solid beverage rich in sheep colostrum and preparation method and application thereof |
| CN112741158A (en) * | 2020-12-29 | 2021-05-04 | 赵新法 | Novel goat milk powder and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN111280257A (en) | Immunoglobulin formula goat milk powder | |
| US5895648A (en) | Composition for feed use comprising lyophilized live lactic bacteria | |
| CN102657262B (en) | Use of polydextrose for simulating the functional attributes of human milk oligosaccharides in formula-fed infants | |
| US20160192689A1 (en) | Encapsulated functional food compositions | |
| CN107594279A (en) | A kind of probiotic powder solid beverage and preparation method thereof | |
| CN103564044B (en) | A kind of Yoghourt containing marine alga and preparation method thereof | |
| US20110052538A1 (en) | Probiotic/non-probiotic combinations | |
| CN105454966A (en) | Probiotics solid beverage for improving gastrointestinal tract and immunity and preparation method thereof | |
| CN104886249B (en) | A kind of lactobacillus fruit juice drink and preparation method thereof | |
| CN102630948A (en) | High-fiber sugar-free fruit flavored type compound prebiotics and preparation method thereof | |
| CN108244252A (en) | Probiotics multielement protein powder and preparation method thereof | |
| MX2012004778A (en) | Nutritional composition for promoting gut microbiota balance and health. | |
| CN103653170A (en) | Stachyose probiotics solid beverage | |
| CN101647491A (en) | Fruit yogurt containing tea and production method thereof | |
| CN104273632A (en) | Probiotics solid beverage and preparation method thereof | |
| CN109198028A (en) | A kind of compound protein powder nutritional food formula containing lactoferrin | |
| CN106720456A (en) | Solid beverage composition containing WPC and preparation method thereof | |
| CN110150667A (en) | A kind of health care product and preparation method thereof for promoting immunity and adjusting function of intestinal canal | |
| CN102578232A (en) | Nutritional yoghurt with egg ingredients | |
| CN108887382A (en) | A kind of lactic acid bacteria fermenting agent, probiotics drinking yoghourt and preparation method thereof | |
| Kontareva et al. | The effect of prebiotic components on the quality of yogurt | |
| CN111937964A (en) | Formula milk powder for promoting overall development of children and application thereof | |
| CN108669563A (en) | A kind of composition, its application and strengthen immunity, the product for improving allergy | |
| CN113768157A (en) | Active probiotic powder and preparation method thereof | |
| CN107889997A (en) | A kind of Freeze-dry Powder of Probioctics solid beverage |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20200616 |